Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1DP5OD024576
National Cancer Institute
Grant: 5K08CA241319
St. Baldrick’s Foundation
Grant: N/A
NCI NIH HHS
Grant: P01 CA250972
University of Wisconsin Carbone Cancer Center
Grant: P30 CA014520
NIH HHS
Grant: DP5 OD024576
NIGMS NIH HHS
Grant: T32 GM140935
NCATS NIH HHS
Grant: UL1 TR002373
National Cancer Institutes of the NIH
Grant: F30CA228315
NIGMS NIH HHS
Grant: T32 GM008692
NCI NIH HHS
Grant: U54 CA232568
NCATS NIH HHS
Grant: TL1 TR002375
NCI NIH HHS
Grant: U01 CA233102
NCI NIH HHS
Grant: K08 CA241319
NCI NIH HHS
Grant: R35 CA197078
National Cancer Institute
Grant: R35-CA197078
National Cancer Institute
Grant: TR002373
National Cancer Institute
Grant: U54-CA232568
National Institutes of Health
Grant: 5T32GM140935-02
Integrated Training For Physician-Scientists
National Institutes of Health
Grant: 5TL1TR002375-04
NRSA Training Core
National Institutes of Health
Grant: 2UL1TR002373-06
University of Wisconsin Institute for Clinical and Translational Research
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: 5F30CA228315-03
Molecular targeted radiotherapy to overcome resistance to in situ cancer vaccination
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Institutes of Health
Grant: 5K08CA241319-04
Utilization of molecular targeted radionuclides to prime immune responses at local and distant metastatic tumor sites
FWCI
1.73
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals